Advertisement
Screener

Allarity Therapeutics, Inc. (ALLR) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Allarity Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Allarity Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $14.82M went out.
  • Fiscal year ended 2025-12-31: from investing, $8.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $10.65M came in.
  • Fiscal year ended 2025-12-31: change in cash, $4.18M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew debtNew shares soldNot split outChange in cash
2025-12-31-$14.82M-$8.00K-$3.19M*$11.14M-$4.18M
2024-12-31-$17.35M-$298.00K$0.00$37.35M-$562.00K*$19.14M
2023-12-31-$12.74M$0.00$6.82M$0.00$4.18M*-$1.75M
2022-12-31-$16.82M$791.00K-$1.31M*-$17.34M
2021-12-31-$14.89M$1.00M$32.13M$1.69M*$19.94M
2020-12-31-$7.25M-$3.00K$3.70M$2.33M*-$1.22M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew debtNew shares soldNot split outChange in cash
2026-06-30-$2.56M*$0.00*$0.00*$0.00*
2026-03-31-$4.49M-$64.00K-$262.00K$0.00$20.00M*$15.18M
2025-12-31-$3.24M*-$484.00K*$0.00*
2025-09-30-$3.41M*-$141.00K*$0.00*$2.45M*
2025-06-30-$5.48M*$0.00*-$2.56M*$0.00*
2025-03-31-$2.69M$0.00$0.00$11.14M$8.46M
2024-12-31-$3.21M*$0.00*$4.24M*
2024-09-30-$5.44M*$0.00*$5.43M*-$562.00K*
2024-06-30-$7.30M*$27.65M-$1.34M*
2024-03-31-$1.40M$40.00K$1.34M*-$19.00K
2023-12-31-$1.67M*-$10.08M*$0.00*$10.60M*
2023-09-30-$5.38M*$10.08M*-$3.63M*
2023-06-30-$2.50M*$2.87M*
2023-03-31-$3.20M$1.16M*-$2.04M
2022-12-31-$2.45M*-$18.00K*$1.00M*
2022-09-30-$4.41M*$0.00*
2022-06-30-$4.21M*$0.00*
2022-03-31-$5.75M$809.00K-$4.95M
2021-12-31-$4.32M*$5.00K*$17.25M*$1.19M*
2021-09-30-$3.73M*$2.77M*
2021-06-30-$4.27M*$10.71M*
2021-03-31-$2.57M$2.33M*-$242.00K
2020-12-31-$2.44M*$795.00K*$1.91M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Lipocine Inc. (LPCN)United States$0.017B-1.79
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B